SlideShare una empresa de Scribd logo
1 de 24
(Inter)National, Multicentred
     Appendicectomy Audit



           Aneel Bhangu
     General Surgery Registrar
West Midlands Research Collaborative
1. First things first

•Why we did it
•What we found
•Future trials




                        2
National Collaborative
•   3rd National meeting
•   National Research Collaborative
•   Simple, easy, accessible idea
•   “All” trainees and hospitals
•   Many questions
    – Feasibility, Structure, Organisation
Aim
• Aim: a national (international),
  multicentred, audit of appendicectomy
• Primary outcome: negative rate
• Secondary outcomes: laparoscopy
  rates, adverse event rates
• Inclusion: appendicectomy, all ages
• Exclude: diagnostic lap
Method
•   Protocol – reviewed by Prof Alderson
•   2 week 5 centre pilot in West Mids
•   2 month multi-centred audit
•   30 centres will recruit approximately 1000
    patients
    – LSRG, WMRC, Mersey, EoE, Trent, Sparcs, PSTRN
    – Hong Kong, Aus, New Zealand
General Surgical Research Collaboratives


                                             Newcastle Surgical
    Scottish Surgical                      Research Collaborative
   Registrars Research
          Group
Data collection
• May 1st- June 30th, 30 day FU
• Access Database with guidance notes
• Strict confidentiality - only anonymised data
  submitted via nhs.net
• Audit registration
• Centrally collated
• Authorship model
To date
• Over 60 centres registered
• 30 have confirmed via unit questionnaire or audit
  registration form
• 15*30 = 450 patients to date
• Database




                                            8
Results
•   95 centres
•   3326 patients
•   89 UK centres
•   6 international centres




                               9
Results II
• (Initial) open appendicectomy: 33.7% (range 3.3-36.8%
  in centres>25 appendicectomies)
• Initial lap approach: 66.3% (8.7-100%)
• Lap conversion in 6.9% (of total)
• A consultant was present in theatre: 23.8% (1.9-84.6%)
• Histologically normal appendix: 20.6% (3.3-36.8%).




                                                 10
Centre specific normal appendicectomy rate                   Centre specific 30 day adverse event rate




Centre specific provision of initial laparoscopic approach   Consultant presence in the operating theatre




                                                                                                         11
Centre specific normal appendicectomy rate                   Centre specific 30 day complication rate




Centre specific provision of initial laparoscopic approach   Consultant presence in the operating theatre




                                                                                                        12
What we did well
• Communication networks
• Speed
• Volume




                            13
Where we could have improved
• Definitions and outcomes
• Even wider communication
• Data collection tools (teething problems only)




                                            14
Summary of aims
• Aim to perform a high quality, multi-centred audit
• Aim to establish a national collaborative
  research network
• Build an RCT from this
Future trials
1.   Lap v open appendicectomy
2.   Lap normal appendix
3.   Right iliac fossa pain of uncertain cause
4.   Operative versus antibiotic treatment




                                         16
Lap normal appendix
• Rationale: no evidence to guide practice at present.
• What we can add: a multicenter trial
• Difficulties:
  – need to randomize everyone to capture target market.
    Combining as an arm of another study is feasible, but will
    increase sample size significantly.
  – Needs one year FU.
  – Endpoint: Reducing LoS; readmissions; adverse events.




                                                            17
lap v open appendicectomy
• Rationale:
  – 0-100% lap rate from 95 centres in the national audit
  – Current 62 RCTs from a Cochrane review mostly single centre
    (only 3 were >3 centres)
  – Mostly used length of stay as primary outcome
• What we can add:
  – a multicenter, national RCT with adverse events as an outcome.
  – Could aim for 1000 patients which may help stablise use of lap
    rates in the UK and beyond.




                                                          18
Difficulties
• High volume centres with lap pathways/ centres with
  high lap rates unlikely to participate, leaving medium size
  centres who currently have mixed rates.
• Learning curves for trainees.
• Need to convince the community of the need for another
  trial on this topic.
• This idea could be trimmed down to selected patients
  rather than all-comers (e.g. those with risk factors for
  post-op adverse events)



                                                    19
RIF pain of uncertain cause
• Rationale: management of undifferentiated RIF pain
  (and undifferentiated acute abdominal pain) is very
  topical and very under-researched.
• Design: Early diagnostic lap v imaging and observation.
  – May be best in females or reproductive age alone.




                                                        20
• What we can add: a multicenter trial – only around 2
  small RCTs currently done on this topic (but this proves
  feasibility). Could randomize the imaging/observation
  arm too.
• Difficulties:
   – Units would need to ensure pathways to access theatre and
     imaging within 24 hours.
   – surgeons may be reluctant to randomize?
   – Potentially slow recruitment?




                                                          21
operative versus antibiotic
      treatment of appendicitis
• Rationale: recent interest and meta-analysis of this as a
  future treatment. Meta-analysis showed 80% avoid
  appendicectomy by 12 months.
• What we can add:
   – no RCT has been done in the UK.
   – Nigel Hall is planning to start a feasibility study in paediatric
     patients, to test whether randomization in the UK climate is
     feasible.
• Difficulties: high quality meta-analysis has showed
  outcomes (but not in UK). Will UK surgeons accept this?


                                                                  22
23
• Questions and discussion




                             24

Más contenido relacionado

La actualidad más candente

POC Breast 1 | 2007 - Systemic Therapy for Metastatic Disease
POC Breast 1 | 2007 - Systemic Therapy for Metastatic DiseasePOC Breast 1 | 2007 - Systemic Therapy for Metastatic Disease
POC Breast 1 | 2007 - Systemic Therapy for Metastatic Diseasertp
 
Nebulized Lidocaine Decreases Discomfort Of Nasogastric Tube Insertion
Nebulized Lidocaine Decreases Discomfort Of Nasogastric Tube InsertionNebulized Lidocaine Decreases Discomfort Of Nasogastric Tube Insertion
Nebulized Lidocaine Decreases Discomfort Of Nasogastric Tube InsertionSrihari Cattamanchi
 
New microsoft office power point presentation
New microsoft office power point presentationNew microsoft office power point presentation
New microsoft office power point presentationMahwish Afzal
 
POC Breast 1 | 2007 - Adjuvant Endocrine Therapy
POC Breast 1 | 2007 -  	Adjuvant Endocrine TherapyPOC Breast 1 | 2007 -  	Adjuvant Endocrine Therapy
POC Breast 1 | 2007 - Adjuvant Endocrine Therapyrtp
 
A distributed data mining network infrastructure for Australian radiotherapy ...
A distributed data mining network infrastructure for Australian radiotherapy ...A distributed data mining network infrastructure for Australian radiotherapy ...
A distributed data mining network infrastructure for Australian radiotherapy ...Cancer Institute NSW
 
Screening for atrial fibrillation
Screening for atrial fibrillationScreening for atrial fibrillation
Screening for atrial fibrillationPHEScreening
 
The Top 5 Ancillary Services For Urology Practices
The Top 5 Ancillary Services For Urology PracticesThe Top 5 Ancillary Services For Urology Practices
The Top 5 Ancillary Services For Urology PracticesClark Love
 
Screening for preterm labour
Screening for preterm labourScreening for preterm labour
Screening for preterm labourPHEScreening
 
Reducing Antimicrobial Prescribing
Reducing Antimicrobial PrescribingReducing Antimicrobial Prescribing
Reducing Antimicrobial PrescribingWalt Whitman
 
Providing actionable healthcare analytics at scale: Insights from the Nationa...
Providing actionable healthcare analytics at scale: Insights from the Nationa...Providing actionable healthcare analytics at scale: Insights from the Nationa...
Providing actionable healthcare analytics at scale: Insights from the Nationa...Nuffield Trust
 
Predictors of MDT review and the impact on lung cancer survival for HNELHD re...
Predictors of MDT review and the impact on lung cancer survival for HNELHD re...Predictors of MDT review and the impact on lung cancer survival for HNELHD re...
Predictors of MDT review and the impact on lung cancer survival for HNELHD re...Cancer Institute NSW
 
ECO 11: Transfer of Care to Pharmacy - Hassan Argomandkhah, Chair of Pharmacy...
ECO 11: Transfer of Care to Pharmacy - Hassan Argomandkhah, Chair of Pharmacy...ECO 11: Transfer of Care to Pharmacy - Hassan Argomandkhah, Chair of Pharmacy...
ECO 11: Transfer of Care to Pharmacy - Hassan Argomandkhah, Chair of Pharmacy...Innovation Agency
 
Evaluating new models of care: Improvement Analytics Unit
Evaluating new models of care: Improvement Analytics UnitEvaluating new models of care: Improvement Analytics Unit
Evaluating new models of care: Improvement Analytics UnitNuffield Trust
 
MicroGuide app, pop up uni, 1pm, 3 september 2015
MicroGuide app, pop up uni, 1pm, 3 september 2015MicroGuide app, pop up uni, 1pm, 3 september 2015
MicroGuide app, pop up uni, 1pm, 3 september 2015NHS England
 

La actualidad más candente (20)

POC Breast 1 | 2007 - Systemic Therapy for Metastatic Disease
POC Breast 1 | 2007 - Systemic Therapy for Metastatic DiseasePOC Breast 1 | 2007 - Systemic Therapy for Metastatic Disease
POC Breast 1 | 2007 - Systemic Therapy for Metastatic Disease
 
Nebulized Lidocaine Decreases Discomfort Of Nasogastric Tube Insertion
Nebulized Lidocaine Decreases Discomfort Of Nasogastric Tube InsertionNebulized Lidocaine Decreases Discomfort Of Nasogastric Tube Insertion
Nebulized Lidocaine Decreases Discomfort Of Nasogastric Tube Insertion
 
New microsoft office power point presentation
New microsoft office power point presentationNew microsoft office power point presentation
New microsoft office power point presentation
 
Warwick evidence
Warwick evidenceWarwick evidence
Warwick evidence
 
Lung cancer
Lung cancerLung cancer
Lung cancer
 
POC Breast 1 | 2007 - Adjuvant Endocrine Therapy
POC Breast 1 | 2007 -  	Adjuvant Endocrine TherapyPOC Breast 1 | 2007 -  	Adjuvant Endocrine Therapy
POC Breast 1 | 2007 - Adjuvant Endocrine Therapy
 
A distributed data mining network infrastructure for Australian radiotherapy ...
A distributed data mining network infrastructure for Australian radiotherapy ...A distributed data mining network infrastructure for Australian radiotherapy ...
A distributed data mining network infrastructure for Australian radiotherapy ...
 
Screening for atrial fibrillation
Screening for atrial fibrillationScreening for atrial fibrillation
Screening for atrial fibrillation
 
The Top 5 Ancillary Services For Urology Practices
The Top 5 Ancillary Services For Urology PracticesThe Top 5 Ancillary Services For Urology Practices
The Top 5 Ancillary Services For Urology Practices
 
Screening for preterm labour
Screening for preterm labourScreening for preterm labour
Screening for preterm labour
 
UOG Journal Club: Single deepest vertical pocket or amniotic fluid index as e...
UOG Journal Club: Single deepest vertical pocket or amniotic fluid index as e...UOG Journal Club: Single deepest vertical pocket or amniotic fluid index as e...
UOG Journal Club: Single deepest vertical pocket or amniotic fluid index as e...
 
Reducing Antimicrobial Prescribing
Reducing Antimicrobial PrescribingReducing Antimicrobial Prescribing
Reducing Antimicrobial Prescribing
 
Providing actionable healthcare analytics at scale: Insights from the Nationa...
Providing actionable healthcare analytics at scale: Insights from the Nationa...Providing actionable healthcare analytics at scale: Insights from the Nationa...
Providing actionable healthcare analytics at scale: Insights from the Nationa...
 
Predictors of MDT review and the impact on lung cancer survival for HNELHD re...
Predictors of MDT review and the impact on lung cancer survival for HNELHD re...Predictors of MDT review and the impact on lung cancer survival for HNELHD re...
Predictors of MDT review and the impact on lung cancer survival for HNELHD re...
 
UOG Journal Club: Prevention of pre-eclampsia by low-molecular-weight heparin...
UOG Journal Club: Prevention of pre-eclampsia by low-molecular-weight heparin...UOG Journal Club: Prevention of pre-eclampsia by low-molecular-weight heparin...
UOG Journal Club: Prevention of pre-eclampsia by low-molecular-weight heparin...
 
1645 ainsworth
1645 ainsworth1645 ainsworth
1645 ainsworth
 
ECO 11: Transfer of Care to Pharmacy - Hassan Argomandkhah, Chair of Pharmacy...
ECO 11: Transfer of Care to Pharmacy - Hassan Argomandkhah, Chair of Pharmacy...ECO 11: Transfer of Care to Pharmacy - Hassan Argomandkhah, Chair of Pharmacy...
ECO 11: Transfer of Care to Pharmacy - Hassan Argomandkhah, Chair of Pharmacy...
 
Evaluating new models of care: Improvement Analytics Unit
Evaluating new models of care: Improvement Analytics UnitEvaluating new models of care: Improvement Analytics Unit
Evaluating new models of care: Improvement Analytics Unit
 
MicroGuide app, pop up uni, 1pm, 3 september 2015
MicroGuide app, pop up uni, 1pm, 3 september 2015MicroGuide app, pop up uni, 1pm, 3 september 2015
MicroGuide app, pop up uni, 1pm, 3 september 2015
 
UOG Journal Club: Ability of a preterm surveillance clinic to triage risk of ...
UOG Journal Club: Ability of a preterm surveillance clinic to triage risk of ...UOG Journal Club: Ability of a preterm surveillance clinic to triage risk of ...
UOG Journal Club: Ability of a preterm surveillance clinic to triage risk of ...
 

Similar a Appendicectomy national meeting

Continuous improvement in cytology - sustaining and accelerating improvement
Continuous improvement in cytology - sustaining and accelerating improvementContinuous improvement in cytology - sustaining and accelerating improvement
Continuous improvement in cytology - sustaining and accelerating improvementNHS Improvement
 
4 Sally Diagnostics UK May 2016 v3.1.pptx
4 Sally Diagnostics UK May 2016 v3.1.pptx4 Sally Diagnostics UK May 2016 v3.1.pptx
4 Sally Diagnostics UK May 2016 v3.1.pptxDESMONDEZIEKE1
 
Implementing oesphageal Doppler in Enhanced Recovery
Implementing oesphageal Doppler in Enhanced RecoveryImplementing oesphageal Doppler in Enhanced Recovery
Implementing oesphageal Doppler in Enhanced RecoveryUniversity of Manchester
 
Francesca Martinelli MedicReS World Congress 2013
Francesca Martinelli MedicReS World Congress 2013Francesca Martinelli MedicReS World Congress 2013
Francesca Martinelli MedicReS World Congress 2013MedicReS
 
Paul Dark - Biomarker guided duration of antibiotic treatment
Paul Dark - Biomarker guided duration of antibiotic treatmentPaul Dark - Biomarker guided duration of antibiotic treatment
Paul Dark - Biomarker guided duration of antibiotic treatmentWalt Whitman
 
HSPIC2016_1011_Butts_Sheena
HSPIC2016_1011_Butts_SheenaHSPIC2016_1011_Butts_Sheena
HSPIC2016_1011_Butts_SheenaSheena Rathell
 
Journal club : Gallstone pancreatitis
Journal club : Gallstone pancreatitisJournal club : Gallstone pancreatitis
Journal club : Gallstone pancreatitisKIST Surgery
 
First steps in improving phlebotomy: the challenge to improve quality, produc...
First steps in improving phlebotomy: the challenge to improve quality, produc...First steps in improving phlebotomy: the challenge to improve quality, produc...
First steps in improving phlebotomy: the challenge to improve quality, produc...NHS Improvement
 
Quanterix Long Sales Presentation_SK
Quanterix Long Sales Presentation_SKQuanterix Long Sales Presentation_SK
Quanterix Long Sales Presentation_SKSteve Klose
 
Accelerating the translation of medical research - 27 June
Accelerating the translation of medical research - 27 JuneAccelerating the translation of medical research - 27 June
Accelerating the translation of medical research - 27 JuneInnovation Agency
 
18 Weeks Whole Pathways Project - National Priority Projects 07/08 Summary Do...
18 Weeks Whole Pathways Project - National Priority Projects 07/08 Summary Do...18 Weeks Whole Pathways Project - National Priority Projects 07/08 Summary Do...
18 Weeks Whole Pathways Project - National Priority Projects 07/08 Summary Do...NHS Improvement
 
OPTCARE Neuro - Palliative care in patients with Multiple Sclerosis (MS)
OPTCARE Neuro - Palliative care in patients with Multiple Sclerosis (MS)OPTCARE Neuro - Palliative care in patients with Multiple Sclerosis (MS)
OPTCARE Neuro - Palliative care in patients with Multiple Sclerosis (MS)MS Trust
 
Star surg uk presentation
Star surg uk presentationStar surg uk presentation
Star surg uk presentationSTARSurg
 
Dr Nick Selby - AKI detection, alerting and intervention-محول.pptx
Dr Nick Selby - AKI detection, alerting and intervention-محول.pptxDr Nick Selby - AKI detection, alerting and intervention-محول.pptx
Dr Nick Selby - AKI detection, alerting and intervention-محول.pptxinfoomallps
 
GlobalSurg II - Protocol Summary
GlobalSurg II - Protocol SummaryGlobalSurg II - Protocol Summary
GlobalSurg II - Protocol SummaryGlobal Surg
 
The right iliac fossa pain treatment audit #RIFTStudy v1.1
The right iliac fossa pain treatment audit #RIFTStudy v1.1The right iliac fossa pain treatment audit #RIFTStudy v1.1
The right iliac fossa pain treatment audit #RIFTStudy v1.1JakeMatthews12
 

Similar a Appendicectomy national meeting (20)

Continuous improvement in cytology - sustaining and accelerating improvement
Continuous improvement in cytology - sustaining and accelerating improvementContinuous improvement in cytology - sustaining and accelerating improvement
Continuous improvement in cytology - sustaining and accelerating improvement
 
4 Sally Diagnostics UK May 2016 v3.1.pptx
4 Sally Diagnostics UK May 2016 v3.1.pptx4 Sally Diagnostics UK May 2016 v3.1.pptx
4 Sally Diagnostics UK May 2016 v3.1.pptx
 
2016_MACLES_APPENDECTOMY_Linkedin
2016_MACLES_APPENDECTOMY_Linkedin2016_MACLES_APPENDECTOMY_Linkedin
2016_MACLES_APPENDECTOMY_Linkedin
 
Implementing oesphageal Doppler in Enhanced Recovery
Implementing oesphageal Doppler in Enhanced RecoveryImplementing oesphageal Doppler in Enhanced Recovery
Implementing oesphageal Doppler in Enhanced Recovery
 
Francesca Martinelli MedicReS World Congress 2013
Francesca Martinelli MedicReS World Congress 2013Francesca Martinelli MedicReS World Congress 2013
Francesca Martinelli MedicReS World Congress 2013
 
Paul Dark - Biomarker guided duration of antibiotic treatment
Paul Dark - Biomarker guided duration of antibiotic treatmentPaul Dark - Biomarker guided duration of antibiotic treatment
Paul Dark - Biomarker guided duration of antibiotic treatment
 
HSPIC2016_1011_Butts_Sheena
HSPIC2016_1011_Butts_SheenaHSPIC2016_1011_Butts_Sheena
HSPIC2016_1011_Butts_Sheena
 
Leanlondon sep11
Leanlondon sep11Leanlondon sep11
Leanlondon sep11
 
Journal club : Gallstone pancreatitis
Journal club : Gallstone pancreatitisJournal club : Gallstone pancreatitis
Journal club : Gallstone pancreatitis
 
First steps in improving phlebotomy: the challenge to improve quality, produc...
First steps in improving phlebotomy: the challenge to improve quality, produc...First steps in improving phlebotomy: the challenge to improve quality, produc...
First steps in improving phlebotomy: the challenge to improve quality, produc...
 
Quanterix Long Sales Presentation_SK
Quanterix Long Sales Presentation_SKQuanterix Long Sales Presentation_SK
Quanterix Long Sales Presentation_SK
 
Accelerating the translation of medical research - 27 June
Accelerating the translation of medical research - 27 JuneAccelerating the translation of medical research - 27 June
Accelerating the translation of medical research - 27 June
 
18 Weeks Whole Pathways Project - National Priority Projects 07/08 Summary Do...
18 Weeks Whole Pathways Project - National Priority Projects 07/08 Summary Do...18 Weeks Whole Pathways Project - National Priority Projects 07/08 Summary Do...
18 Weeks Whole Pathways Project - National Priority Projects 07/08 Summary Do...
 
Leanlondon mar12 presentation
Leanlondon mar12 presentationLeanlondon mar12 presentation
Leanlondon mar12 presentation
 
OPTCARE Neuro - Palliative care in patients with Multiple Sclerosis (MS)
OPTCARE Neuro - Palliative care in patients with Multiple Sclerosis (MS)OPTCARE Neuro - Palliative care in patients with Multiple Sclerosis (MS)
OPTCARE Neuro - Palliative care in patients with Multiple Sclerosis (MS)
 
Enhanced Recovery Canada Presentation
Enhanced Recovery Canada PresentationEnhanced Recovery Canada Presentation
Enhanced Recovery Canada Presentation
 
Star surg uk presentation
Star surg uk presentationStar surg uk presentation
Star surg uk presentation
 
Dr Nick Selby - AKI detection, alerting and intervention-محول.pptx
Dr Nick Selby - AKI detection, alerting and intervention-محول.pptxDr Nick Selby - AKI detection, alerting and intervention-محول.pptx
Dr Nick Selby - AKI detection, alerting and intervention-محول.pptx
 
GlobalSurg II - Protocol Summary
GlobalSurg II - Protocol SummaryGlobalSurg II - Protocol Summary
GlobalSurg II - Protocol Summary
 
The right iliac fossa pain treatment audit #RIFTStudy v1.1
The right iliac fossa pain treatment audit #RIFTStudy v1.1The right iliac fossa pain treatment audit #RIFTStudy v1.1
The right iliac fossa pain treatment audit #RIFTStudy v1.1
 

Appendicectomy national meeting

  • 1. (Inter)National, Multicentred Appendicectomy Audit Aneel Bhangu General Surgery Registrar West Midlands Research Collaborative
  • 2. 1. First things first •Why we did it •What we found •Future trials 2
  • 3. National Collaborative • 3rd National meeting • National Research Collaborative • Simple, easy, accessible idea • “All” trainees and hospitals • Many questions – Feasibility, Structure, Organisation
  • 4. Aim • Aim: a national (international), multicentred, audit of appendicectomy • Primary outcome: negative rate • Secondary outcomes: laparoscopy rates, adverse event rates • Inclusion: appendicectomy, all ages • Exclude: diagnostic lap
  • 5. Method • Protocol – reviewed by Prof Alderson • 2 week 5 centre pilot in West Mids • 2 month multi-centred audit • 30 centres will recruit approximately 1000 patients – LSRG, WMRC, Mersey, EoE, Trent, Sparcs, PSTRN – Hong Kong, Aus, New Zealand
  • 6. General Surgical Research Collaboratives Newcastle Surgical Scottish Surgical Research Collaborative Registrars Research Group
  • 7. Data collection • May 1st- June 30th, 30 day FU • Access Database with guidance notes • Strict confidentiality - only anonymised data submitted via nhs.net • Audit registration • Centrally collated • Authorship model
  • 8. To date • Over 60 centres registered • 30 have confirmed via unit questionnaire or audit registration form • 15*30 = 450 patients to date • Database 8
  • 9. Results • 95 centres • 3326 patients • 89 UK centres • 6 international centres 9
  • 10. Results II • (Initial) open appendicectomy: 33.7% (range 3.3-36.8% in centres>25 appendicectomies) • Initial lap approach: 66.3% (8.7-100%) • Lap conversion in 6.9% (of total) • A consultant was present in theatre: 23.8% (1.9-84.6%) • Histologically normal appendix: 20.6% (3.3-36.8%). 10
  • 11. Centre specific normal appendicectomy rate Centre specific 30 day adverse event rate Centre specific provision of initial laparoscopic approach Consultant presence in the operating theatre 11
  • 12. Centre specific normal appendicectomy rate Centre specific 30 day complication rate Centre specific provision of initial laparoscopic approach Consultant presence in the operating theatre 12
  • 13. What we did well • Communication networks • Speed • Volume 13
  • 14. Where we could have improved • Definitions and outcomes • Even wider communication • Data collection tools (teething problems only) 14
  • 15. Summary of aims • Aim to perform a high quality, multi-centred audit • Aim to establish a national collaborative research network • Build an RCT from this
  • 16. Future trials 1. Lap v open appendicectomy 2. Lap normal appendix 3. Right iliac fossa pain of uncertain cause 4. Operative versus antibiotic treatment 16
  • 17. Lap normal appendix • Rationale: no evidence to guide practice at present. • What we can add: a multicenter trial • Difficulties: – need to randomize everyone to capture target market. Combining as an arm of another study is feasible, but will increase sample size significantly. – Needs one year FU. – Endpoint: Reducing LoS; readmissions; adverse events. 17
  • 18. lap v open appendicectomy • Rationale: – 0-100% lap rate from 95 centres in the national audit – Current 62 RCTs from a Cochrane review mostly single centre (only 3 were >3 centres) – Mostly used length of stay as primary outcome • What we can add: – a multicenter, national RCT with adverse events as an outcome. – Could aim for 1000 patients which may help stablise use of lap rates in the UK and beyond. 18
  • 19. Difficulties • High volume centres with lap pathways/ centres with high lap rates unlikely to participate, leaving medium size centres who currently have mixed rates. • Learning curves for trainees. • Need to convince the community of the need for another trial on this topic. • This idea could be trimmed down to selected patients rather than all-comers (e.g. those with risk factors for post-op adverse events) 19
  • 20. RIF pain of uncertain cause • Rationale: management of undifferentiated RIF pain (and undifferentiated acute abdominal pain) is very topical and very under-researched. • Design: Early diagnostic lap v imaging and observation. – May be best in females or reproductive age alone. 20
  • 21. • What we can add: a multicenter trial – only around 2 small RCTs currently done on this topic (but this proves feasibility). Could randomize the imaging/observation arm too. • Difficulties: – Units would need to ensure pathways to access theatre and imaging within 24 hours. – surgeons may be reluctant to randomize? – Potentially slow recruitment? 21
  • 22. operative versus antibiotic treatment of appendicitis • Rationale: recent interest and meta-analysis of this as a future treatment. Meta-analysis showed 80% avoid appendicectomy by 12 months. • What we can add: – no RCT has been done in the UK. – Nigel Hall is planning to start a feasibility study in paediatric patients, to test whether randomization in the UK climate is feasible. • Difficulties: high quality meta-analysis has showed outcomes (but not in UK). Will UK surgeons accept this? 22
  • 23. 23
  • 24. • Questions and discussion 24